{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:44:50Z","timestamp":1787813090119,"version":"build-2784847793"},"reference-count":75,"publisher":"Houston Methodist DeBakey Heart & Vascular Center","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,6]]},"DOI":"10.14797\/mdcvj.1163","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T11:58:15Z","timestamp":1670327895000},"page":"27-39","source":"Crossref","is-referenced-by-count":13,"title":["Opportunities for Earlier Diagnosis and Treatment of Cardiac Amyloidosis"],"prefix":"10.14797","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6754-3670","authenticated-orcid":false,"given":"Trejeeve","family":"Martyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3576-3660","authenticated-orcid":false,"given":"Andres Carmona","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry D.","family":"Estep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7251-3003","authenticated-orcid":false,"given":"Mazen","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5826","reference":[{"issue":"16","key":"key20221206065433_B1","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","year":"2021","journal-title":"Eur Heart J"},{"issue":"14","key":"key20221206065433_B2","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","article-title":"Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis","volume":"135","year":"2017","journal-title":"Circulation"},{"issue":"12 Suppl 3","key":"key20221206065433_B3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3949\/ccjm.84.s3.02","article-title":"Cardiac amyloidosis: An update on diagnosis and treatment","volume":"84","year":"2017","journal-title":"Cleve Clin J Med"},{"issue":"8","key":"key20221206065433_B4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","article-title":"Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice","volume":"7","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"4","key":"key20221206065433_B5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jaccao.2021.09.003","article-title":"AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: JACC: CardioOncology State-of-the-Art Review","volume":"3","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"9","key":"key20221206065433_B6","article-title":"Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis","volume":"12","year":"2019","journal-title":"Circ Heart Fail"},{"issue":"1","key":"key20221206065433_B7","first-page":"e7","article-title":"Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association","volume":"142","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"key20221206065433_B8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis","volume":"140","year":"2019","journal-title":"Circulation"},{"issue":"30","key":"key20221206065433_B9","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","year":"2018","journal-title":"Eur Heart J"},{"issue":"10","key":"key20221206065433_B10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System","volume":"68","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"key20221206065433_B11","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review","volume":"73","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"key20221206065433_B12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jchf.2020.04.007","article-title":"Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis","volume":"8","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"38","key":"key20221206065433_B13","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","year":"2015","journal-title":"Eur Heart J"},{"issue":"3","key":"key20221206065433_B14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study","volume":"40","year":"2008","journal-title":"Ann Med"},{"issue":"1","key":"key20221206065433_B15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.119.041015","article-title":"The Truth Is Unfolding About Transthyretin Cardiac Amyloidosis","volume":"140","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"key20221206065433_B16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.14797\/mdcvj.1050","article-title":"Cardiac Amyloidosis Treatment","volume":"18","year":"2022","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"9","key":"key20221206065433_B17","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","article-title":"Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies","volume":"6","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"key20221206065433_B18","article-title":"Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy","volume":"3","year":"2016","journal-title":"Open Heart"},{"issue":"11","key":"key20221206065433_B19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"key20221206065433_B20","first-page":"391","article-title":"Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"43","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"key20221206065433_B21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.CIR.63.1.188","article-title":"M-mode and two-dimensional echocardiographic features in cardiac amyloidosis","volume":"63","year":"1981","journal-title":"Circulation"},{"issue":"9","key":"key20221206065433_B22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jchf.2022.06.006","article-title":"Racial and Genetic Differences in Presentation of Transthyretin Amyloid Cardiomyopathy With Impaired Left Ventricular Function","volume":"10","year":"2022","journal-title":"JACC Heart Fail"},{"issue":"19","key":"key20221206065433_B23","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","year":"2012","journal-title":"Heart"},{"issue":"1","key":"key20221206065433_B24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment","volume":"28","year":"2018","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"key20221206065433_B25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/europace\/euz314","article-title":"Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis","volume":"22","year":"2020","journal-title":"Europace"},{"issue":"13","key":"key20221206065433_B26","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.120.052136","article-title":"Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy","volume":"143","year":"2021","journal-title":"Circulation"},{"issue":"11","key":"key20221206065433_B27","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.recesp.2017.05.018","article-title":"Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope","volume":"70","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"5","key":"key20221206065433_B28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1536\/ihj.15-005","article-title":"Contribution of Electrocardiogram in the Differentiation of Cardiac Amyloidosis and Nonobstructive Hypertrophic Cardiomyopathy","volume":"56","year":"2015","journal-title":"Int Heart J"},{"issue":"17","key":"key20221206065433_B29","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release","volume":"72","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"key20221206065433_B30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2017.9236","article-title":"Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis","volume":"318","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"key20221206065433_B31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/03009734.2014.895786","article-title":"Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis","volume":"119","year":"2014","journal-title":"Ups J Med Sci"},{"issue":"1","key":"key20221206065433_B32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00750729","article-title":"Chemical heterogeneity of amyloid in the carpal tunnel syndrome","volume":"412","year":"1987","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"4","key":"key20221206065433_B33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1212\/CPJ.0000000000000640","article-title":"Carpal tunnel syndrome and associated symptoms as first manifestation of hATTR amyloidosis","volume":"9","year":"2019","journal-title":"Neurol Clin Pract"},{"key":"key20221206065433_B34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.amjcard.2021.08.049","article-title":"Cardiac Amyloidosis Screening at Trigger Finger Release Surgery","volume":"160","year":"2021","journal-title":"Am J Cardiol"},{"issue":"1","key":"key20221206065433_B35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/13506129.2015.1135792","article-title":"Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis","volume":"23","year":"2016","journal-title":"Amyloid"},{"issue":"22","key":"key20221206065433_B36","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.jacc.2020.04.022","article-title":"Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week","volume":"75","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"key20221206065433_B37","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1253\/circj.CJ-19-0255","article-title":"Combination of Commonly Examined Parameters Is a Useful Predictor of Positive 99 mTc-Labeled Pyrophosphate Scintigraphy Findings in Elderly Patients With Suspected Transthyretin Cardiac Amyloidosis","volume":"83","year":"2019","journal-title":"Circ J"},{"key":"key20221206065433_B38","article-title":"A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"11","key":"key20221206065433_B39","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2019.08.001","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging","volume":"25","year":"2019","journal-title":"J Card Fail"},{"issue":"11","key":"key20221206065433_B40","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.cardfail.2019.08.002","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization","volume":"25","year":"2019","journal-title":"J Card Fail"},{"issue":"2","key":"key20221206065433_B41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jchf.2020.09.011","article-title":"Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT","volume":"9","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"1","key":"key20221206065433_B42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"key20221206065433_B43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"key20221206065433_B44","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","year":"2021","journal-title":"N Engl J Med"},{"key":"key20221206065433_B45","article-title":"The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era","year":"2022","journal-title":"J Card Fail"},{"issue":"4","key":"key20221206065433_B46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaccao.2021.08.009","article-title":"Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey","volume":"3","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"6","key":"key20221206065433_B47","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jcmg.2020.08.027","article-title":"Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution","volume":"14","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"key20221206065433_B48","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jhsa.2019.06.016","article-title":"Carpal Tunnel Syndrome: A Potential Early, Red-Flag Sign of Amyloidosis","volume":"44","year":"2019","journal-title":"J Hand Surg Am"},{"issue":"6","key":"key20221206065433_B49","first-page":"1","article-title":"Conversion of 99mtechnetium-pyrophosphate scintigraphy in a patient with hereditary ATTR amyloidosis: importance of repeat scanning","volume":"4","year":"2020","journal-title":"Eur Heart J Case Rep"},{"issue":"10","key":"key20221206065433_B50","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2022.06.026","article-title":"Screening for Cardiac Amyloidosis 5 to 15 Years After Surgery for Bilateral Carpal Tunnel Syndrome","volume":"80","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"key20221206065433_B51","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/13506129.2021.1950681","article-title":"Association between spinal stenosis and wild-type ATTR amyloidosis","volume":"28","year":"2021","journal-title":"Amyloid"},{"issue":"2","key":"key20221206065433_B52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/modpathol.2014.102","article-title":"Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis","volume":"28","year":"2015","journal-title":"Mod Pathol"},{"key":"key20221206065433_B53","article-title":"Analysis of lumbar spine stenosis specimens for identification of amyloid","year":"2022","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"key20221206065433_B54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis","volume":"77","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"key20221206065433_B55","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/CIRCRESAHA.121.319900","article-title":"Heart Failure Subtypes and Cardiomyopathies in Women","volume":"130","year":"2022","journal-title":"Circ Res"},{"issue":"11","key":"key20221206065433_B56","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jchf.2021.06.007","article-title":"Spironolactone in Patients With an Echocardiographic HFpEF Phenotype Suggestive of Cardiac Amyloidosis: Results From TOPCAT","volume":"9","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"3","key":"key20221206065433_B57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jchf.2020.12.005","article-title":"The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials","volume":"9","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"38","key":"key20221206065433_B58","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","year":"2017","journal-title":"Eur Heart J"},{"issue":"29","key":"key20221206065433_B59","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/eurheartj\/ehaa170","article-title":"Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation","volume":"41","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"key20221206065433_B60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1404852","article-title":"The amyloidogenic V122I transthyretin variant in elderly black Americans","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"key20221206065433_B61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jchf.2021.09.006","article-title":"Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults","volume":"10","year":"2022","journal-title":"JACC Heart Fail"},{"issue":"6","key":"key20221206065433_B62","first-page":"1","article-title":"Association of the V122I Transthyretin Amyloidosis Genetic Variant With Cardiac Structure and Function in Middle-aged Black Adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study","volume":"6","year":"2020","journal-title":"JAMA Cardiol"},{"key":"key20221206065433_B63","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: US National Library of Medicine; c2022. Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations (SCAN-MP); 2022 May 23 [cited 2022 Nov 17]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03812172"},{"issue":"11","key":"key20221206065433_B64","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamacardio.2021.3070","article-title":"Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction","volume":"6","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"1","key":"key20221206065433_B65","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1038\/s41467-021-22876-9","article-title":"A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy","volume":"12","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"key20221206065433_B66","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/jamacardio.2021.0185","article-title":"Utility of a Deep-Learning Algorithm to Guide Novices to Acquire Echocardiograms for Limited Diagnostic Use","volume":"6","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"16","key":"key20221206065433_B67","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/CIRCULATIONAHA.118.034338","article-title":"Fully Automated Echocardiogram Interpretation in Clinical Practice","volume":"138","year":"2018","journal-title":"Circulation"},{"issue":"11","key":"key20221206065433_B68","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.mayocp.2021.04.023","article-title":"Artificial Intelligence-Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis","volume":"96","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"key20221206065433_B69","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1038\/s41467-021-22877-8","article-title":"Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms","volume":"12","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"key20221206065433_B70","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jaccao.2021.09.005","article-title":"Toward Population-Based Genetic Screening for Hereditary Amyloidosis","volume":"3","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"1","key":"key20221206065433_B71","article-title":"Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry","volume":"11","year":"2021","journal-title":"Sci Rep"},{"issue":"22","key":"key20221206065433_B72","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2019.17935","article-title":"Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic\/Latino Ancestry","volume":"322","year":"2019","journal-title":"JAMA"},{"issue":"9","key":"key20221206065433_B73","article-title":"A circulating, disease-specific, mechanism-linked biomarker for ATTR polyneuropathy diagnosis and response to therapy prediction","volume":"118","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20221206065433_B74","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: US National Library of Medicine; c2022. Monitorial of Early Disease Progression in hereditary Transthyretin Amyloidosis (MED-hATTR); 2022 Mar 28 [cited 2022 Nov 11]. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03431896"},{"issue":"4","key":"key20221206065433_B75","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic Resonance in Transthyretin Cardiac Amyloidosis","volume":"70","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["Methodist DeBakey Cardiovascular Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T11:59:09Z","timestamp":1670327949000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.houstonmethodist.org\/articles\/10.14797\/mdcvj.1163\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,12,6]]}},"alternative-id":["10.14797\/mdcvj.1163"],"URL":"https:\/\/doi.org\/10.14797\/mdcvj.1163","relation":{},"ISSN":["1947-6108"],"issn-type":[{"value":"1947-6108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}